Trade JnJ JNJ

Sell
 Buy

JnJ live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

JnJ News

Sophia Claire 2025 Sep 12, 10:10

Dollar Bear Market Outlook: A Comprehensive Assessment and Analysis

Noah Lee 2025 Sep 12, 09:10

Fed Independence, Mission Creep, and the Interest Rate Battle: A Deeper Dive

Ghko B 2025 Sep 11, 16:00

Trending Stocks Predictions: NIO Stock, TTD Stock, NFLX, AMZN

stocks
Ghko B 2025 Sep 11, 16:00

SMCI Stock Price Prediction: Is Super Micro Computer Stock Undervalued?

stocks
Frances Wang 2025 Sep 11, 16:00

E-Commerce Stock Price Analysis: Why Chewy (CHWY) Stock Is Up Today?

stocks
Tommy Yap 2025 Jul 12, 21:00

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

Forex Indices
Tommy Yap 2025 Apr 12, 16:00

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Forex Indices
ECB set to cut rates for the third time this year
Neil Wilson 2024 Oct 10, 16:00

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Forex Indices
US earnings season kicks off, ECB expected to hold rates steady
Neil Wilson 2024 Jul 11, 21:00

Week ahead: US earnings season kicks off, ECB hold expected

Forex Indices
Oil steady, gold bearish trend
Neil Wilson 2024 Jan 22, 08:15

Europe Tries to Ride on US Coat-tails

Stocks Forex Commodities Indices

Latest news

Show more
Noah Lee 2025 Sep 12, 10:20

US-Japan Joint Statement: Reaffirming Market-Driven Exchange Rates

Emma Rose 2025 Sep 12, 09:20

Goldman Sachs, UBS Raise Gold Price Forecasts for 2025

Noah Lee 2025 Sep 12, 09:20

Albania Appoints AI Minister to Combat Corruption in Public Procurement

Emma Rose 2025 Sep 11, 15:20

Dalio: Gold as a Hedge Against Mounting Debt Risks

Ava Grace 2025 Sep 11, 14:20

Switzerland Proposes US Gold Refinery to Reduce Tariffs

Noah Lee 2025 Sep 11, 14:20

NATO and EU on Edge After Russian Drone Enters Poland: A Critical Test

Liam James 2025 Sep 11, 10:20

Economists Anticipate BOJ Rate Hike in Q4 Amidst Global Uncertainties

Sophia Claire 2025 Sep 11, 10:20

Fed Rate Cut Debate Intensifies: Employment Data Revision Fuels Calls for Action

Info

Spread

1.09

Spread (%)

0.6128 %

Leverage

1:2

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

423362068480

Shares Outstanding

2408339968

Earnings Date (Next)

2001-06-13

Div Yield

2025-09-09

Ex-Dividend Date

2025-08-26

Forward annual dividend rate

5.2

Forward annual dividend yield

0.0296

EPS

9.33

Learn more about this instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Sep 11, 16:00

Latest XRP Updates: How to Trade Ripple XRP (XRPUSD) Crypto CFDs?

Crypto
Frances Wang 2025 Sep 11, 16:00

How to Trade Dogecoin CFDs in 2025: IC Markets, eToro, XTB, IG

Crypto
Frances Wang 2025 Sep 11, 16:00

Forex CFD Trading Platforms Review (2025): What Traders Need to Know?

Forex
Trustpilot